Skip to main content
logo
Island Pharmaceuticals Limited (ASX:ILA)
Australia flag Australia · Delayed Price · Currency is AUD
0.4300
+0.0050 (1.18%)
Sep 2, 2026, 12:21 PM AEST

Island Pharmaceuticals Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Market Capitalization
1261123310812
Market Cap Growth
126.64%240.21%238.62%26.43%-34.48%-48.02%
Enterprise Value
11310629946
Last Close Price
0.420.380.140.080.090.13

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Forward PE
-1.84----
PS Ratio
444.94397.83277.977.74--
PB Ratio
9.348.364.626.434.322.73
P/TBV Ratio
9.898.844.626.434.322.73

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
EV/Sales Ratio
-373.52244.397.37--

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Debt / Equity Ratio
---0.28--
Net Debt / Equity Ratio
-0.96-0.96-1.01-0.81-1.12-1.11
Net Debt / EBITDA Ratio
1.261.26----
Asset Turnover
0.030.030.020.55--
Quick Ratio
24.4324.4322.092.447.648.28
Current Ratio
24.6224.6222.272.457.778.44
Return on Equity (ROE)
-95.50%-95.50%-90.37%-173.37%-92.75%-48.65%
Return on Assets (ROA)
-60.11%-60.11%-49.16%-77.59%-52.32%-30.44%
Return on Capital Employed (ROCE)
-76.80%-76.80%-55.30%-188.50%-162.90%-65.10%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
-7.83%-8.75%-11.86%-29.34%-36.66%-22.12%
Buyback Yield / Dilution
-55.94%-55.94%-91.98%-11.11%-0.42%-334.32%